A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial
Part of paid clinical trials in Seattle, Washington.
- Sponsor
- Fred Hutchinson Cancer Center
- Study ID
- NCT07490860
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - 77 Years
- Healthy Volunteers
- Accepted
Interventions
- Educational Intervention — OTHERAttend LCS decision-making support session
- Survey Administration — OTHERAncillary studies
- Interview — OTHERAncillary studies
- Electronic Health Record Review — OTHERAncillary studies
Study Details
This clinical trial develops and studies whether a restorative justice-based lung cancer screening (LCS) decision-making support intervention tailored for Black individuals increases LCS among Black community members. Lung cancer remains the leading cause of cancer deaths among Black men and women. LCS with yearly low-dose chest computed tomography (CT) is recommended for people with current or recent tobacco use (within 15 years) who are aged 50-80 with at least a 20 pack-year smoking history. LCS lowers lung cancer death by 20%; however, data shows that LCS completion remains low among minority groups in the United States. The restorative justice-based LCS decision-making support intervention in this trial has been specifically tailored to meet the needs of Black individuals. It is designed to reduce racial unfairness by promoting trust, shared understanding, and empowerment in clinical decision making while addressing the social and historical circumstances of health inequalities. This may be an effective way to increase LCS among Black community members.
Key Dates
- First listed
- Mar 24, 2026
- Start date
- Aug 1, 2026
- Status verified
- Jun 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 45 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SCREENING
Arms
- Experimental: Screening [Lung cancer screening (LCS) decision-making support session]Participants attend an in-person restorative justice-based LCS decision-making support session over 2-3 hours on study.
Primary Outcome Measure
Intervention acceptability [ Time Frame: At post-intervention (Day 1) ]
Central Contacts
- Matthew Triplette, MD, MPH206-667-6335
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Fred Hutch/University of Washington Cancer Consortium | Seattle | Washington | 98109 | Matthew Triplette, MD, MPH (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Seattle, WA
Related Studies
- Evaluating the Impact of Centralized Interventions on Lung Cancer Screening Adherence in Community Settings, ACCELL TrialEnrolling By Invitation · Fred Hutchinson Cancer Center · Seattle, Washington
- The Vanguard Study: Testing a New Way to Screen for CancerRecruiting · National Cancer Institute (NCI) · Pleasanton, California
- Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS TrialNot Yet Recruiting · Fred Hutchinson Cancer Center · Auburn, Washington
- An Educational Intervention (Lung Toolkit) for Improving Knowledge About Lung Cancer and Screening Among American Indian and Alaskan Native Cigarette Smokers, Lung PATHS TrialNot Yet Recruiting · Fred Hutchinson Cancer Center · Seattle, Washington